Login / Signup

Incorporation of a Ligand Peptide for Immune Inhibitory Receptor LAIR-1 on Biomaterial Surfaces Inhibits Macrophage Inflammatory Responses.

Yoon Kyung KimShu-Hui ChuJessica Y HsiehCody M KamokuAndrea J TennerWendy F LiuSzu-Wen Wang
Published in: Advanced healthcare materials (2017)
Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is an inhibitory receptor broadly expressed on immune cells, with its ligands residing within the extracellular matrix protein collagen. In this study, surfaces are modified with a LAIR-1 ligand peptide (LP), and it is observed that macrophages cultured on LAIR-1 LP-conjugated surfaces exhibit significantly reduced secretion of inflammatory cytokines in response to proinflammatory stimuli that reflect an injured environment. These downregulated mediators include TNF-α, MIP-1α, MIP-1β, MIP-2, RANTES, and MIG. Knockdown of LAIR-1 using siRNA abrogates this inhibition of cytokine secretion, supporting the specificity of the inhibitory effect to this receptor. These results are the first to demonstrate that integration of LAIR-1 ligands with biomaterials could suppress inflammatory responses.
Keyphrases
  • extracellular matrix
  • biofilm formation
  • binding protein
  • rheumatoid arthritis
  • photodynamic therapy
  • endothelial cells
  • staphylococcus aureus
  • adipose tissue
  • drug delivery
  • peripheral blood
  • pseudomonas aeruginosa